HyBryte™ Clinical Summary Published in “Expert Opinion on Investigational Drugs”
“We are pleased to have Dr. Poligone and his team review the compelling data generated from the HyBryte™ clinical program, enabling the medical community to evaluate its safety, efficacy and utility in early-stage CTCL,” stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. “We look forward to continuing our work with Dr. Poligone and all our principal investigators as we move towards completing patient enrollment in the FLASH2 Phase 3 study later this year, with an interim analysis of this study expected in 2Q 2026.”
Share:
More News
“This research collaboration with AbCellera directly aligns with Jazz’s rare disease strategy, expanding our focus on GI cancers and building on our existing expertise in oncology,” said Josh Allen, Ph.D., chief scientific officer, oncology, Jazz Pharmaceuticals. “We look forward to collaborating with AbCellera to progress potential best-in-class TCE multispecific antibodies
AIM Chief Executive Officer Thomas K. Equels stated: “AIM hopes to utilize the exploratory biomarker data generated through DURIPANC to design a Phase 3 study involving Ampligen in the treatment of pancreatic cancer. We are particularly interested in evaluating whether specific biomarkers may help to identify ‘super-responder’ patient subsets most
“We are committed to improving the treatment of glioblastoma and are grateful to our investigators and the patients and families who made the TRIDENT trial possible,” said Uri Weinberg, MD, PhD, Chief Medical and Innovation Officer, Novocure. “The study did not meet its primary endpoint, but the results from TRIDENT
“Fast Track Designation is a valuable step forward for givastomig and for patients with first-line HER2-negative metastatic gastric cancer,” said Phillip Dennis, MD, PhD, Chief Medical Officer of NovaBridge. “Phase 1b results demonstrate robust efficacy and favorable overall tolerability in combination with immunochemotherapy. Responses were deep and durable across a